| Code | CSB-RA904931A0HU |
| Size | US$210 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
| Application | Recommended Dilution |
|---|---|
| IF | 1:20-1:200 |
EPAS1, also known as HIF-2α, serves as a master transcriptional regulator of the cellular response to hypoxia, orchestrating gene expression programs that govern angiogenesis, erythropoiesis, and metabolic adaptation. Unlike its closely related family member HIF-1α, EPAS1 demonstrates distinct tissue-specific expression patterns and target gene preferences, making it particularly relevant to researchers investigating tumor progression, cardiovascular remodeling, and metabolic disorders. The protein's role in promoting tumor vascularization and its emerging significance in clear cell renal carcinoma have positioned it as both a biomarker of interest and a potential therapeutic target.
This recombinant monoclonal antibody, generated against a synthetic peptide derived from human HIF-2α, offers the reproducibility and consistency that demanding research applications require. Because the antibody sequence is defined and produced recombinantly in rabbit host cells, you can expect uniform performance across experiments and between lot numbers, eliminating the variability that can complicate longitudinal studies or multi-site collaborations.
Validation through immunofluorescence microscopy demonstrates clear nuclear localization in HeLa cells, consistent with EPAS1's function as a transcription factor. The recommended working dilution range of 1:20 to 1:200 for immunofluorescence provides flexibility to optimize signal intensity based on your specific experimental conditions and detection systems. The antibody has also been validated for ELISA applications, supporting quantitative detection workflows.
Whether you are characterizing hypoxic signaling pathways, investigating tumor microenvironment dynamics, or exploring metabolic reprogramming in cardiovascular disease models, this antibody provides a reliable tool for detecting human EPAS1 in your research.
There are currently no reviews for this product.